What Tonegawa' s Nobel Doesn't Mean

In the wake of the news that Susumu Tonegawa of MIT had been chosen as the 1987 Nobel laureate in medicine (See THE SCIENTIST, November 2, 1987, P. 4), an article by Stephen Kreider Yoder appeared in the Wall Street Journal (October 14, 1987, p. 30) under the headline “Native Son’s Nobel Award Is Japan’s Loss: Scientist’s Prize Points Up Research System’s Failings.” The writer asserted that Tonegawa’s prize is “as much an embarrassment as a victo

Written byEugene Garfield
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

In the wake of the news that Susumu Tonegawa of MIT had been chosen as the 1987 Nobel laureate in medicine (See THE SCIENTIST, November 2, 1987, P. 4), an article by Stephen Kreider Yoder appeared in the Wall Street Journal (October 14, 1987, p. 30) under the headline “Native Son’s Nobel Award Is Japan’s Loss: Scientist’s Prize Points Up Research System’s Failings.” The writer asserted that Tonegawa’s prize is “as much an embarrassment as a victory for Japan’s research community [and] illustrates the dire shortcomings of Japan’s research system.” (See “Japan’s Embarrassing Victory “p. 24.) This conclusion stems from Tonegawa’s personal history. Although he earned a B.S. degree from Kyoto University in 1963, he left the country thereafter and has studied and worked outside Japan ever since. He received a Ph.D. from the University of California at San Diego in 1968, was a postdoctoral fellow there from 1968-1969, a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies